Stay updated on Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.
Latest updates to the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page
- Check107 days agoChange DetectedNew recruitment sites have been added across various countries including Bulgaria, China, Colombia, France, Italy, Japan, Poland, Slovakia, Spain, Turkey, and the UK, while one site in Israel has been removed.SummaryDifference6%
- Check124 days agoChange DetectedThe study has added 12 new recruiting sites across various locations including Maryland, Czechia, France, Germany, Japan, the Netherlands, Poland, Romania, Slovakia, and South Africa, while removing the Tokyo Medical and Dental University Hospital site.SummaryDifference2%
- Check131 days agoChange DetectedThe website has added new recruitment sites for clinical studies across various locations, including 223 sites in the District of Columbia, multiple sites in China, and several in Europe, while the total number of studies has increased from 205 to 223.SummaryDifference4%
- Check139 days agoChange DetectedThe website has added new recruiting sites for a gastroenterology study in Romania, including locations in București, Târgu Mureș, and Timișoara, while removing previous entries from September 19 and 23.SummaryDifference0.9%
- Check146 days agoChange DetectedNew clinical studies have been added across various locations including the United States, China, and Europe, with a notable increase in recruitment sites for gastroenterology research.SummaryDifference10%
- Check153 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.2%
Stay in the know with updates to Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.